Study Population

Add ONTARGET® Trial Programme to My Alerts (what's this?)

Print | Send to a friend

ONTARGET®: 25,620 patients enrolled from 40 countries

TRANSCEND®: 5,926 patients enrolled from 40 countries

Inclusion criteria

  • ≥ 55 years of age
  • At high risk of cardiovascular disease:
    • coronary artery disease
    • peripheral arterial occlusive disease
    • stroke or recent transient ischaemic attack
    • diabetes with end-organ damage
  • Intolerant to ACE inhibitors (TRANSCEND® ONLY)

Exclusion criteria

  • Overt heart failure
  • Arterial hypertension (>160/100 mmHg)
  • Diabetic patients with proteinuria (TRANSCEND® ONLY)

References

Toolbox

Calendar

Tools and Downloads

My Alerts

You will shortly be able to create your own personal alerts service bringing the latest ONTARGET® news and updates direct to your inbox. Watch this space for more information.